Adamis Pharmaceuticals | ADMP - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Adamis Pharmaceuticals

Adamis Pharmaceuticals reported $-8942910 in Net Income for its fiscal quarter ending in March of 2023.


Net Income Change
Adamis Pharmaceuticals ADMP:US USD -8942910 5.62M
Brainstorm Cell Therapeutics BCLI:US USD -5059000 41K
Cara Therapeutics CARA:US USD -26665000 3.67M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
Glaxosmithkline GSK:US GBP 1.49B 5M
Merck & Co MRK:US USD 2.82B 196M
Pfizer PFE:US USD 5.54B 548M
RedHill Biopharma RDHL:US USD -3729000 31.97M